who is eligible for glp 1 Blog | Discover Your Weight Journey—Get Informed — Navigate Weight & Metabolic Who Qualifies for Semaglutide GLP-1

Fan Z, Aman Y, Ahmed I, Chetelat G, Landeau B, Ray Chaudhuri K, et al

Across multiple phase III trials, tirzepatide has consistently produced greater reductions in glycated hemoglobin and body weight compared with established GLP 1 receptor agonists and other standard therapies

There are concerns that drug could retrigger a restrictive eating disorder in someone diagnosed with one previously, or even trigger one in someone who hadnt had one before

It reduces meal-related hyperglycemia (for 24 hours after administration) by increasing insulin secretion (only) when required by increasing glucose levels, delaying gastric emptying, and suppressing prandial glucagon secretion

Conclusions Collectively, a plethora of preclinical studies have demonstrated that GLP-1 and its RAs exert direct cardioprotective, vascular protective, and antiinflammatory effects that complement their metabolic actions